More S'poreans Going Abroad for IVF to Choose Baby's Gender
By Asia One,
Asia One
| 08. 22. 2011
More and more Singaporeans are heading overseas for medical procedures which allow them to choose their babies' gender.
According to The Straits Times, foreign destinations such as the United States, and increasingly Thailand, let parents choose the gender of their babies through a procedure known as preimplantation genetic diagnosis (PGD), which is banned in Singapore.
These places are also well-known for their skills in in-vitro fertilisation (IVF).
Having sons important for people of Chinese ancestry
The managing director of Marvel IVF Solutions, an IVF facility in Bangkok, said 90 per cent of Singaporeans, Chinese nationals and Hong Kongers ask for boys.
That is because males are seen as heirs and capable of taking care of their siblings, the director said.
Other facilities such as Safe Fertility and PGD Centre in Bangkok and Fertility Institutes in Los Angeles also saw the same requests by Singaporean patrons, according to The Straits Times.
Embryos screened for gender or genetic diseases or both
PGD is carried out with IVF treatment and the embryos are screened for gender or genetic diseases or both, during the...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
